Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05274048
Title Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.